Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `5,797 Target Price `6,560. 3QFY2017 Result Update Automobile. 3-year price chart

Similar documents
Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `7,622 Target Price `8,501. 1QFY2018 Result Update Automobile

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `5,715 Target Price `6,006. 2QFY2017 Result Update Automobile. 3-year price chart

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

Mahindra & Mahindra Ltd.

Hindustan Media Ventures

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Mahindra & Mahindra Ltd.

Amber Enterprises India Ltd

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `4,496 Target Price `4,960. 2QFY2016 Result Update Automobile. 3-year price chart

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Procter & Gamble Hygiene & Health Care

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Mahindra & Mahindra Ltd.

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Bajaj Auto ACCUMULATE. Performance Highlights. CMP `2,815 Target Price `3,151. 1QFY2018 Result Update Automobile. 24 July 2017

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

Transport Corporation of India

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Century Plyboards Ltd

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

Quick take. Ashok Leyland Ltd BUY. Scrappage policy to drive faster growth. Target Price. Investment Period 12 Months. 3-year price chart

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Quick take. VIP Industries BUY. Travelling smart on the luggage track. CMP Target Price `153 ` year daily price chart

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

TVS Motor Company BUY. Performance Highlights. CMP Target Price `39 `45. 2QFY2013 Result Update Automobile. Quarterly highlights (Standalone)

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

Hero MotoCorp NEUTRAL. Performance Highlights. CMP `2,245 Target Price - 4QFY2012 Result Update Automobile. Investment Period - Key financials

TV Today Network BUY. Go with the market leader. CMP Target Price `297 `363. Initiating Coverage Media. 3-year price chart

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

Tata Consultancy Services (TCS)

Matrimony.com Ltd BUY. A complete package from matchmaking to wedding. Target Price. Initiating Coverage Internet Software & Services

Simplex Infrastructures

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

Cairn India ACCUMULATE. Performance Highlights. CMP Target Price `338 `382. 2QFY2013 Result Update Oil & Gas. Quarterly highlights (Consolidated)

Mahindra & Mahindra BUY. CMP Target Price `860 `990. Company Update Automobile

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Lupin 1QFY2018 Result Update

Apollo Micro Systems Ltd

Avenue Supermarts Limited

MRF BUY. Performance Highlights. CMP `40,703 Target Price `47,548. 1QSY2015 Result Update Tyre

Lupin BUY. Performance Highlights. CMP `1,493 Target Price `1,809. 2QFY2017 Result Update Pharmaceutical. 3-year price chart

Prakash Industries BUY. Performance Highlights. CMP Target Price `81 `124. 3QFY2011 Result Update Steel

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `440 Target Price. 3QFY2017 Result Update Pharmaceutical. Investment Period -

Alembic BUY. Performance Highlights. Target Price. 1QFY2011 Result Update Pharmaceutical. Investment Period 12 months

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

Tech Mahindra ACCUMLATE. Performance Highlights `495 `526. CMP Target Price. 2QFY2018 Result Update IT

BGR Energy Systems NEUTRAL. Performance Highlights CMP. `235 Target Price - 3QFY2013 Result Update Capital Goods. Investment Period -

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Cadila Healthcare ACCUMULATE. Performance Highlights. CMP 860 Target Price QFY2013 Result Update Pharmaceutical. Key financials (Consolidated)

Quick take. Aditya Birla Nuvo BUY. Deep Value. Valuation Methodology. Exhibit 1: ABNL s Business Structure

Varroc Engineering Ltd.

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

HT Media ACCUMULATE. Performance Highlights CMP. `102 Target Price `113. 3QFY2013 Result Update Media. Investment Period 12 months

Newgen Software Technologies Ltd

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Transcription:

3QFY2017 Result Update Automobile January 27, 2017 Maruti Suzuki Performance Highlights ACCUMULATE CMP `5,797 Target Price `6,560 Y/E March (` cr) 3QFY17 3QFY16 % chg (yoy) 2QFY17 % chg (qoq) Net Sales 16,865 15,013 12.3 17,843 (5.5) EBITDA 2,489 2,145 16.0 3,037 (18.1) EBITDA Margin (%) 14.8 14.3 46 bp 17.0 (226) bp Adj. PAT 1,745 1,183 47.5 2,398 (27.3) Strong operating performance aided by decent UV volumes: Maruti Suzuki (MSIL) reported a good set of numbers for 3QFY2017 with yoy 12.3% revenue growth and yoy 47.5% growth in its PAT. EBITDA came at `2,489cr, a yoy growth of 16.0%. EBITDA margins were at 14.8% v/s. 14.3% in 3QFY2016 and 17.0% in 2QFY2017. On sequential basis, revenue witnessed a 5.5% decline due to demonetization. On the volume front, company reported yoy 5.8% and 1.6% decline in mini and compact segment vehicles respectively. The UV segment, however, reported yoy 25.5% growth due to the performance of recently launched models. Net realizations remained at `429,272 per unit showing a yoy growth of 8.65%. RM cost per unit at `301,453 increased by 9.59% yoy due to the rise in input costs. Management has indicated that showroom footfalls have come back to normalcy indicating that 4QFY2017 numbers are likely to be better than 3QFY2017. Outlook and valuation: MSIL has continued to report double digit numbers due to the strong performance of its utility vehicles. Company expects to launch one model each year, which is likely to sustain its growth momentum in the near term. MSIL has indicated that showroom footfalls have come back to normalcy, which were impacted immediately after the demonetisation announcement. We believe that 4QFY2017 revenue growth is likely to be better than 3QFY2017. With the Gujarat plant nearing commissioning, the company will see de-bottlenecking of capacity constraints. With the strong performance, MSIL is likely to gain further market share. At CMP, MSIL is trading at P/E of 22.8x and 18.6x its FY2017E and FY2018E earnings respectively. We value MSIL on 21x of its FY2018E EPS of `312 with a target price of `6,560 with Accumulate rating on the stock. Key financials (post SPIL merger) Y/E March (` cr) FY2015 FY2016 FY2017E FY2018E Net Sales 48,606 56,350 66,847 82,165 % chg 14.0 15.9 18.6 22.9 Net Profit 3,711 4,571 7,664 9,433 % chg 33.4 23.2 67.7 23.1 OPM (%) 13.8 15.9 16.3 16.6 EPS (Rs) 122.9 151.4 253.8 312.4 P/E (x) 47.2 38.3 22.8 18.6 P/BV (x) 7.4 6.5 5.2 4.2 RoE (%) 15.7 16.9 23.0 22.9 RoCE (%) 17.5 22.6 24.0 25.3 EV/Sales (x) 3.3 2.7 2.2 1.7 EV/EBITDA (x) 24.3 17.5 14.0 10.7 ; Note: CMP as of January 25, 2016 Investment Period 12 Months Stock Info Sector Automobile Market Cap (` cr) 175,110 Net Debt (` cr) (17,593) Beta 52 Week High / Low Avg. Daily Volume Face Value (`) BSE Sensex Nifty Reuters Code Bloomberg Code Shareholding Pattern (%) Promoters MF / Banks / Indian Fls FII / NRIs / OCBs Indian Public / Others 0.8 5,972/3,202 76,907 5 27,708 8,603 MRTI.BO MSIL@IN Abs. (%) 3m 1yr 3yr Sensex (0.5) 13.2 31.1 Maruti Suzuki (1.3) 41.9 227.0 3-year price chart Shrikant Akolkar 022-3935 7800 Ext: 6846 Shrikant.akolkar@angelbroking.com Please refer to important disclosures at the end of this report 1 6,000 5,000 4,000 3,000 2,000 1,000 0 56.2 12.2 24.7 6.9 Jan-14 Apr-14 Jul-14 Oct-14 Jan-15 Apr-15 Jul-15 Oct-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17

Exhibit 1: Quarterly financial performance Y/E March (` cr) 3QFY17 3QFY16 % chg (yoy) 2QFY17 % chg (qoq) 9MFY17 9MFY16 % chg (yoy) Net Sales 16,865 15,013 12.3 17,843 (5.5) 49,628 42,141 17.8 Raw-material cost 11,674 10,293 13.4 12,074 (3.3) 33,873 28,579 18.5 (% of Sales) 69.2 68.6 67.7 68.3 67.8 Staff cost 617 502 22.9 519 18.8 1,715 1,381 24.2 (% of Sales) 3.7 3.3 2.9 3.5 3.3 Other Expenses 2,085 2,073 0.6 2,212 (5.7) 6,298 5,724 10.0 (% of Sales) 12.4 13.8 12.4 12.7 13.6 Total Expenditure 14,376 12,868 11.7 14,805 (2.9) 41,886 35,683 17.4 Operating Profit 2,489 2,145 16.0 3,037 (18.1) 7,742 6,458 19.9 OPM (%) 14.8 14.3 17.0 15.6 15.3 Interest 29 24 18.9 20 47.2 68 61 10.8 Depreciation 635 722 (12.1) 630 0.8 1,904 2,063-7.7 Other Income 592 243 144.1 813 (27.2) 1,888 923 104.6 PBT (excl. Extr. Items) 2,417 1,641 47.3 3,200 (24.5) 7,658 5,256 45.7 Extr. Income/(Expense) PBT (incl. Extr. Items) 2,417 1,641 47.3 3,200 (24.5) 7,658 5,256 45.7 (% of Sales) 14.3 10.9 17.9 15.4 12.5 Provision for Taxation 673 458 46.8 802 (16.2) 2,031 1,468 38.3 (% of PBT) 27.8 27.9 25.1 26.5 27.9 Reported PAT 1,745 1,183 47.5 2,398 (27.3) 5,628 3,788 48.6 Adj PAT 1,745 1,183 47.5 2,398 (27.3) 5,628 3,788 48.6 Adj. PATM 10.3 7.9 13.4 11.3 9.0 Equity capital (cr) 151 151 151 151 151 Reported EPS (`) 57.75 39.16 47.5 79.38 (27.3) 186.30 125.40 48.6 January 27, 2017 2

Exhibit 2: Quarterly volume performance Volume (units) Q3FY17 Q3FY16 % chg (yoy) Q2FY17 % chg (qoq) 9MFY17 9MFY16 % chg (yoy) A: Mini: Alto, WagonR 104,342 110,810 (5.8) 114,936 (9.2) 312,001 326,598 (4.5) A: Compact: Swift, Celerio, Dzire, Baleno 150,899 153,423 (1.6) 156,284 (3.4) 447,204 435,695 2.6 A: Mid-Size: Ciaz 15,504 14,240 8.9 17,920 (13.5) 47,114 38,160 23.5 Total Passenger cars 270,745 278,473 (2.8) 289,140 (6.4) 8,06,319 8,00,453 0.7 B: Utility Vehicles: Gypsy, Ertiga 34,252 27,291 25.5 52,611 (34.9) 126,211 79,055 59.6 C: Vans: Omni, Eeco 51,295 37,231 37.8 41,197 24.5 129,050 92,450 39.6 D: LCV 211 0 83 294 0 n.a Total Domestic (includes LCV) 356,503 342,995 3.9 383,031 (6.9) 10,61,874 971,958 9.3 Total Exports 30,748 31,187 (1.4) 35,440 (13.2) 92,291 96,888 (4.7) Total Volume 387,251 374,182 3.5 418,471 (7.5) 11,54,165 10,68,846 8.0 MSIL saw reduced footfalls immediately after the demonetisation announcement, however, footfalls have been restored, indicating that the impact of note ban is likely to vanish earlier than expected. Total volumes during the quarter were at 387,251 showing a yoy growth of 3.5%. Domestic volumes grew by 3.94% while export volumes contracted by 1.4%. Company reported 5.84% decline in its mini vehicle segment; the compact class vehicle sales growth was flat. Mid size, vans and UV segment vehicles showed growth of 8.9%, 37.8% and 25.5% respectively, indicating that the performance was better than entry level cars. During the quarter, company sold 211 LCVs compared to 83 LCVs in 3QFY2017. Company continues to outperform the industry growth. During the quarter industry growth was 1.8% while company growth was at 3.9%. Realisation per vehicle grew 8.65% yoy owing to a better product mix with higher volumes of utility vehicles. The contribution/vehicle also improved by ~9.6% due to better product mix. We estimate domestic and export realizations to be `4.27 lakh and `4.50 lakh showing yoy growth 8.31% and 12.54% respectively. During the quarter company paid royalty at 5.5% of net sales v/s. 6.1% of net sales in 2QFY2017. Company is targeting millennial group (age group 18-28) as potential customers for newly launched hatchback Ignis. January 27, 2017 3

Exhibit 3: Growth slows due to demonetisation Exhibit 4: Realisation & contribution per vehicle 400,000 300,000 200,000 100,000 Q1FY15 Q2FY15 Q3FY15 Q4FY15 Q1FY16 Q2FY16 Q3FY16 Q4FY16 Q1FY17 Volumes yoy growth (%) Q2FY17 Q3FY17 20.0 15.0 10.0 5.0 0.0 425,000 400,000 375,000 350,000 325,000 300,000 Q1FY15 Q2FY15 Q3FY15 Q4FY15 Q1FY16 Net realization (`) Q2FY16 Q3FY16 Q4FY16 Q1FY17 Q2FY17 Q3FY17 Contribution / Vehicle (`) 150,000 130,000 110,000 90,000 70,000 50,000 30,000 10,000-10,000 Exhibit 5: Quarterly revenue and realization performance Q1FY16 Q2FY16 Q3FY16 Q4FY16 Q1FY17 Q2FY17 *Q3FY17 Domestic revenue (` cr) 11,698 12,360 13,523 13,548 13,334 16,030 15,242 Change yoy (%) 19.00 16.66 22.50 12.25 13.98 29.69 12.58 Domestic realization (`) 382,680 382,344 394,254 406,352 413,663 418,494 427,547 Change yoy (%) 5.36 3.82 5.43 7.12 8.10 9.45 8.31 Export revenue (` cr) 1,380 1,130 1,245 1,382 1,352 1,565 1,381 Change yoy (%) 11.0 (19.3) 1.7 14.9 (2.0) 38.5 11.0 Export realization (`) 387,260 375,840 399,077 511,681 517,948 441,591 449,272 Change yoy (%) (8.87) (8.22) (6.40) 25.65 33.75 17.49 12.54, * Estimates Exhibit 6: EBITDA growth at 16%, margins at 14.8% 3,000 2,500 2,000 1,500 1,000 500 0 Q1FY15 Q2FY15 Q3FY15 Q4FY15 Q1FY16 Q2FY16 Q3FY16 Q4FY16 Q1FY17 Q2FY17 Q3FY17 EBITDA (`cr) EBITDA margins (%) 18.0 17.0 16.0 15.0 14.0 13.0 12.0 11.0 10.0 Exhibit 7: PAT grows despite demonetisation impact 2,500 2,000 1,500 1,000 500 0 Q1FY15 Q2FY15 Q3FY15 Q4FY15 Q1FY16 Q2FY16 Q3FY16 Q4FY16 Q1FY17 Q2FY17 Q3FY17 Net profit (`cr) Net margin (%) 16.0 14.0 12.0 10.0 8.0 6.0 4.0 2.0 0.0 January 27, 2017 4

Conference call Key highlights Company has indicated that share of diesel vehicles has declined to 40% and company has 30% market share in the diesel vehicles. While exports showed flat growth, company expects to reach the target of 124,000 exports by end of the year. The discount during the quarter was at `19,048 v/s. 21,997 in 3QFY2016 and `16,100 in 2QFY2017. Company has said that demand scenario remains strong but has ruled out price increase of its products. It has also said that recovery in the rural market is on the lines of recovery of urban markets, implying that rural demand has picked up very strong and that entry level volumes are likely to show good numbers in 4QFY2017. The commissioning of the Gujarat plant is around the corner, and it will ease capacity constraints. Government employees segment constitute ~20% of MSIL s sales v/s. 14-15% in the last quarter. In the last quarter, company had indicated that it had dedicated a team to cater to this segment and we believe that 20% contribution from govt. employees is an effect of this. It also indicated that inquiries are growing form the first time buyers, however, the sentiment of small business owners remained impacted. Waiting period for Baleno is 24 weeks while that for Ignis is 8-10 weeks. Company has indicated that Suzuki will take care of the Gujarat plant capex. MSIL has guided FY2017E full year capex of `3,500cr. Company expects higher maintenance capex due to its aging plants (Gurgaon and Manesar). January 27, 2017 5

Investment arguments MSIL seeing faster recovery after demonetisation: The automobile demand in India has seen the impact of demonetization in 3QFY2017 however Maruti with its strong performance has continued to grow in double digits. We believe, MSIL is seeing faster recovery than its peers. Further, the low interest rate is expected to boost the consumer sentiment, which will benefit MSIL due to its high market share. Overall, we expect resilient demand in 4QFY2017, which will result in growth in volumes for the Automobile companies. MSIL expected to gain market share: MSIL is the largest passenger car manufacturer in the country and enjoys a leadership position. MSIL s major product portfolio is towards the petrol cars, where it enjoys highest market shares among its peers. The lower petrol prices have benefitted the company and continued weakness in crude prices is expected to benefit the company by keeping petrol prices at lower levels. In 2QFY2017, MSIL s share of petrol vehicles in total passenger vehicle industry stood at 59.2% compared to 53.7% in 2QFY2016. Strong dealership network and improved product mix is expected to benefit the company in gaining further market share. We also expect the passenger vehicle penetration to go up in the country, which will help MSIL, as it already covers most parts of the country through its robust dealership network. Gujarat plant to ease capacity constraints: MSIL is currently seeing capacity constraints, which have led to company overstretching its existing capacity. In 2QFY2017, MSIL s capacity utilization was more than 100% and indicates that it may not be able to cater the strong demand without capacity expansion. Gujarat capacity is expected to address these constraints by adding additional capacity of 250,000 vehicles per annum from 4QFY2017 onwards. Ignis to help MSIL reporting double digit growth: MSIL s new launch, Ignis a hatchback, is likely to take the company s growth story forward. The last few launches have been received well by the market and we expect the same to continue. Ignis is targeted for tech savvy millennial consumers (18-25 age groups). Company has started booking and has already received ~10,000+ booking and the waiting period is 8-10 weeks. January 27, 2017 6

Outlook and valuation MSIL has continued to report double digit numbers due to the strong performance of its utility vehicles. Company expects to launch one model each year, which is likely to sustain its growth momentum in the near term. MSIL has indicated that showroom footfalls have come back to normalcy, which were impacted immediately after the demonetisation announcement. We believe that 4QFY2017 revenue growth is likely to be better than 3QFY2017. With the Gujarat plant nearing commissioning, the company will see debottlenecking of capacity constraints. With the strong performance, MSIL is likely to gain further market share. At CMP, MSIL is trading at P/E of 22.8x and 18.6x its FY2017E and FY2018E earnings respectively. We value MSIL on 21x of its FY2018E EPS of `312 with a target price of `6,560 with Accumulate rating on the stock. Exhibit 8: Key assumptions Y/E March FY2013 FY2014 FY2015 FY2016E FY2017E FY2018E Domestic unit sales 1,050,859 1,053,688 1,170,702 1,305,351 1,424,099 1,575,324 YoY growth (%) 4.4 0.3 11.1 11.5 9.1 10.6 Exports unit sales 120,388 101,352 121,713 123,897 124,000 145,721 YoY growth (%) (5.5) (15.8) 20.1 1.8 0.1 17.5 Total volumes 1,171,247 1,155,040 1,292,415 1,429,248 1,548,099 1,721,045 YoY growth (%) 3.3 (1.4) 11.9 10.6 8.3 11.2 Per unit domestic realization 405,502 404,719 415,183 431,688 425,888 466,969 Per unit exports realization 378,784 408,645 380,641 386,797 499,737 590,330 Per unit realisation (blended) 363,822 369,206 376,083 394,266 431,803 477,414 YoY growth (%) 18.8 1.5 1.9 4.8 9.5 10.6 Per unit RM 277,611 271,112 270,873 271,331 297,209 326,934 YoY growth (%) 12.1 (2.3) (0.1) 0.2 9.5 10.0 Company background Maruti Suzuki (MSIL), a subsidiary of Suzuki Motor Corporation (SMC), Japan (which holds a 56% stake in MSIL), is the largest passenger car company in India, accounting for ~47% of the domestic passenger car market. MSIL operates from two facilities in India (Gurgaon and Manesar) with an installed capacity of 1.5mn units. Company is also in process of commissioning production at Gujarat plant, which will help the company to ease its capacity constraints. Company in the last two years has moved in premium products with launch of Baleno, Vitara, S-Cross and Ciaz. Also, MSIL has steadily increased its presence internationally, and exports now account for ~9% of its overall sales volume and same is expected to increase going ahead. January 27, 2017 7

Profit and loss statement (post SPIL merger) Y/E March (` cr) FY2014 FY2015 FY2016 FY2017E FY2018E Total operating income 43,792 49,971 57,746 67,822 83,288 % chg 2.8 14.1 15.6 17.4 22.8 Total Expenditure 38,605 43,258 48,768 56,958 69,635 Cost of Materials 31,315 35,008 38,780 46,011 56,267 Personnel 1,368 1,607 1,989 2,406 3,098 Others Expenses 5,922 6,643 7,999 8,541 10,271 EBITDA 5,187 6,713 8,979 10,865 13,653 % chg 22.6 29.4 33.7 21.0 25.7 (% of Net Sales) 11.8 13.4 15.5 16.0 16.4 Depreciation& Amort. 2,084 2,470 2,824 2,804 3,155 EBIT 3,103 4,243 6,155 8,060 10,498 % chg 122.7 36.7 45.1 31.0 30.2 (% of Net Sales) 7.1 8.5 10.7 11.9 12.6 Interest & other Charges 176 206 82 91 103 Other Income 732 832 462 2,479 2,707 (% of PBT) 20.0 17.1 7.1 23.7 20.7 Recurring PBT 3,659 4,868 6,535 10,448 13,102 % chg 81.5 33.1 34.2 59.9 25.4 Prior Period & Extra. Exp./(Inc.) - - - - - PBT (reported) 3,659 4,868 6,535 10,448 13,102 Tax 876 1,157 1,964 2,784 3,669 (% of PBT) 23.9 23.8 30.0 26.6 28.0 PAT (reported) 2,783 3,711 4,571 7,664 9,433 Add: Share of earnings of asso. - - - - - Less: Minority interest (MI) - - - - - PAT after MI (reported) 2,783 3,711 4,571 7,664 9,433 ADJ. PAT 2,783 3,711 4,571 7,664 9,433 % chg 16.3 33.4 23.2 67.7 23.1 (% of Net Sales) 6.4 7.4 7.9 11.3 11.3 Basic EPS (`) 92.1 122.9 151.4 253.8 312.4 Fully Diluted EPS (`) 92.1 122.9 151.4 253.8 312.4 % chg 16.3 33.4 23.2 67.7 23.1 January 27, 2017 8

Balance sheet statement (post SPIL merger) Y/E March (` cr) FY2014 FY2015 FY2016 FY2017E FY2018E SOURCES OF FUNDS Equity Share Capital 151 151 151 151 151 Reserves& Surplus 20,827 23,553 26,856 33,218 41,047 Shareholders Funds 20,978 23,704 27,007 33,369 41,198 Minority Interest - - - - - Total Loans 1,824 516 231 231 231 Deferred Tax Liability 691 587 625 625 625 Other Liabilities 437 398 424 424 424 Total Liabilities 23,930 25,205 28,288 34,649 42,479 APPLICATION OF FUNDS Gross Block 22,702 26,462 29,409 32,909 37,209 Less: Acc. Depreciation 11,911 14,202 16,641 19,446 22,601 Net Block 10,790 12,259 12,768 13,463 14,608 Capital Work-in-Progress 2,621 1,883 1,007 1,007 1,007 Investments 10,118 12,814 17,786 22,060 27,936 Current Assets 7,070 6,593 7,635 9,881 13,223 Inventories 1,706 2,686 3,132 3,663 4,502 Sundry Debtors 1,414 1,070 1,299 1,648 2,026 Cash 630 18 39 1,093 1,683 Loans & Advances 1,629 1,426 1,807 1,939 2,876 Other Assets 1,692 1,393 1,359 1,537 2,136 Current liabilities 6,775 8,451 11,059 11,913 14,447 Net Current Assets 295 (1,857) (3,424) (2,032) (1,224) Deferred Tax Asset 105 106 151 151 151 Mis. Exp. not written off - - - - - Total Assets 23,930 25,205 28,288 34,649 42,479 Note: Cash and bank balance includes term deposits with banks January 27, 2017 9

Cash flow statement (post SPIL merger) Y/E March (` cr) FY2014 FY2015 FY2016 FY2017E FY2018E Profit before tax 3,659 4,868 6,535 10,448 13,102 Depreciation 2,084 2,470 2,824 2,804 3,155 Change in Working Capital 756 746 1,466 (337) (219) Interest / Dividend (Net) (106) 43 (80) 91 103 Direct taxes paid (832) (1,041) (1,910) (2,784) (3,669) Others (658) (766) (401) - - Cash Flow from Operations 4,904 6,321 8,433 10,222 12,473 (Inc.)/ Dec. in Fixed Assets (3,498) (3,157) (2,594) (3,500) (4,300) (Inc.)/ Dec. in Investments (1,395) (1,253) (4,582) (4,274) (5,876) Cash Flow from Investing (4,893) (4,410) (7,176) (7,774) (10,176) Issue of Equity - - 1 - - Inc./(Dec.) in loans 378 (1,328) (235) 0 0 Dividend Paid (Incl. Tax) (242) (363) (755) (1,303) (1,604) Interest / Dividend (Net) (293) (831) (246) (91) (103) Cash Flow from Financing (156) (2,522) (1,236) (1,394) (1,707) Inc./(Dec.) in Cash (145) (611) 21 1,054 590 Opening Cash balances 775 630 18 39 1,093 Closing Cash balances 630 18 39 1,093 1,683 Note: Closing Cash balances excludes term deposits with banks and unclaimed dividend accounts January 27, 2017 10

Key ratios Y/E March FY2014 FY2015 FY2016 FY2017E FY2018E Valuation Ratio (x) P/E (on FDEPS) 62.9 47.2 38.3 22.8 18.6 P/CEPS 36.0 28.3 23.7 16.7 13.9 P/BV 8.3 7.4 6.5 5.2 4.2 Dividend yield (%) 0.1 0.2 0.4 0.7 0.9 EV/Sales 3.8 3.3 2.7 2.2 1.7 EV/EBITDA 32.0 24.3 17.5 14.0 10.7 EV / Total Assets 5.4 4.8 4.0 3.3 2.6 Per Share Data (`) EPS (Basic) 92.1 122.9 151.4 253.8 312.4 EPS (fully diluted) 92.1 122.9 151.4 253.8 312.4 Cash EPS 161.1 204.7 244.9 346.6 416.8 DPS 8.0 12.0 25.0 43.1 53.1 Book Value 694.5 784.7 894.3 1,104.9 1,364.2 Returns (%) ROCE 13.6 17.5 22.6 24.0 25.3 Angel ROIC (Pre-tax) 25.7 37.3 65.4 77.2 88.9 ROE 13.3 15.7 16.9 23.0 22.9 Turnover ratios (x) Asset Turnover (Gross Block) 1.9 1.9 2.0 2.1 2.2 Inventory / Sales (days) 15 20 20 20 20 Receivables (days) 12 8 8 9 9 Payables (days) 46 45 49 44 44 WC cycle (ex-cash) (days) (20) (17) (21) (15) (15) January 27, 2017 11

Research Team Tel: 022-39357800 E-mail: research@angelbroking.com Website: www.angelbroking.com DISCLAIMER Angel Broking Private Limited (hereinafter referred to as Angel ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and Metropolitan Stock Exchange Limited. It is also registered as a Depository Participant with CDSL and Portfolio Manager with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel Broking Private Limited is a registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration number INH000000164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. Angel or its associates/analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate the contrary view, if any. The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Pvt. Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Pvt. Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Pvt. Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Neither Angel Broking Pvt. Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Disclosure of Interest Statement Maruti Suzuki 1. Financial interest of research analyst or Angel or his Associate or his relative No 2. Ownership of 1% or more of the stock by research analyst or Angel or associates or relatives No 3. Served as an officer, director or employee of the company covered under Research No 4. Broking relationship with company covered under Research No Ratings (Based on expected returns Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%) over 12 months investment period): Reduce (-5% to -15%) Sell (< -15) January 27, 2017 12